Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thrombin is a serine protease and a key enzyme in the blood coagulation cascade. It is produced from prothrombin (coagulation factor II) and functions by converting soluble fibrinogen into insoluble fibrin strands to form blood clots. Thrombin also activates several other coagulation factors (V, VIII, XI, XIII), promotes platelet activation and aggregation via protease-activated receptors on platelets, and has both procoagulant and anticoagulant roles depending on its interactions with cofactors such as thrombomodulin. Medically used forms of thrombin include those derived from human plasma (human thrombin), bovine sources (bovine thrombin), or produced recombinantly (recombinant human thrombin). These products are primarily used topically during surgical procedures to control bleeding when standard techniques are ineffective or impractical[1][2][3][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thrombin.